MedPath

Effectiveness of Phone Calls Intervention on Diabetic Patients After Ambulatory Discharge of a Tertiary Care Center

Not Applicable
Completed
Conditions
Diabetes Mellitus
Interventions
Other: Phone Calls Support and Primary Care
Other: Primary Care
Registration Number
NCT02768480
Lead Sponsor
Hospital de Clinicas de Porto Alegre
Brief Summary

The study is a randomized clinical trial, controlled, open label that aimed to compare two groups after discharge of a tertiary care: type 2 diabetes patients followed exclusively by primary care (control group) and patients followed by primary care and supported by phone calls (intervention group).

Detailed Description

The investigators designed a randomized controlled trial. Patients with stable and controlled type 2 diabetes, and considered to be eligible to discharge from specialized care to primary care will be included. Patients with severe neuropathy, not controlled ischemic heart disease and nephropathy stage IV/V will be excluded. Enrolled patients will be randomized in two groups: follow-up supported by periodic nurse phone calls plus primary care (intervention group) or followed by primary care team (control group). The intervention group will receive regular telephone calls (every 3 months for 1 year) and will have a toll-free number to resolve questions about the disease management. Main outcome is the glycemic control between groups after 1 year of follow-up. Secondary outcomes include: rate of hypoglycaemia, blood pressure control,emergency visits, nephropathy progression and death.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
147
Inclusion Criteria
  • Patients with type 2 diabetes;
  • Patients who met discharges criteria according to endocrinology team;
  • Patients with HbA1C < 8%.
Exclusion Criteria
  • Patients with stage IV or V nephropathy;
  • Patients with not controlled Ischemic heart disease;
  • Patients with severe autonomous or peripheral neuropathy.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Phone Calls Support and Primary CarePhone Calls Support and Primary CarePatients will be followed by primary care team and supported by periodic nurse phone calls.
Primary CarePrimary CarePatients will be followed by primary care team exclusively.
Primary Outcome Measures
NameTimeMethod
Glycemic Control1 year

Evaluation after 1 year of discharge with HbA1c

Secondary Outcome Measures
NameTimeMethod
Visits to the doctor, nurse, nutritionist, psychologist1 year

Evaluation after 1 year of discharge with a structured questionnaire

Death1 year

Evaluation after 1 year of discharge with telephone contact and active search

Care satisfaction with diabetes treatment1 year

Evaluation after 1 year of discharge with a structured questionnaire

Emergency visits because of diabetes acute complications1 year

Evaluation after 1 year of discharge with a structured questionnaire

Antiplatelet therapy/ statin use1 year

Evaluation after 1 year of discharge with a structured questionnaire

Major cardiovascular events1 year

Evaluation after 1 year of discharge with a structured questionnaire

Retinopathy emergence or worsening1 year

Evaluation after 1 year of discharge with retinography and ophthalmologist advice if is necessary.

Rate of referring to tertiary care1 year

Evaluation after 1 year of discharge with a structured questionnaire

Hypoglycaemic rate1 year

Evaluation after 1 year of discharge with a structured questionnaire

Treatment adherence1 year

Evaluation after 1 year of discharge with the Brief Medication Questionnaire

Lipid control1 year

Evaluation after 1 year of discharge with blood lipid levels

Nephropathy emergence or worsening1 year

Evaluation after 1 year of discharge with microalbuminuria and blood creatinine measurement

Trial Locations

Locations (1)

Hospital de Clinicas de Porto Alegre

🇧🇷

Porto Alegre, Rio Grande Do Sul, Brazil

© Copyright 2025. All Rights Reserved by MedPath